Naushad Rais1, Yogesh K Chawla, Krishan K Kohli. 1. Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, UT-160 012, India.
Abstract
OBJECTIVES: To phenotype 200 healthy North Indians for cytochrome P450 3A (CYP3A) activity by measuring urinary ratio of 6beta-OH-cortisol/cortisol (6beta-OH-CS/CS) and to genotype the subjects demonstrating low and high CYP3A activity for the presence of CYP3A4*1B, *2, *4, *5, *6 and *10 alleles. METHODS: Morning spot urine samples were collected from 200 healthy North Indians. CS and 6beta-OH-CS were extracted and quantified by HPLC. Genotyping was performed by polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP). RESULTS: Urinary 6beta-OH-CS/CS ratio demonstrated a mean of 52.0 +/- 46 (1.1-290). North Indians demonstrated unimodal distribution with respect to urinary 6beta-OH-CS/CS ratio. On the basis of phenotypes, the subjects were divided into three groups demonstrating low (n = 50), intermediate (n = 100) and high (n = 50) CYP3A activity. These groups demonstrated 6beta-OH-CS/CS ratio of 13.4 +/- 5.2 (1.1-21.0), 40 +/- 11.9 (21.2-63.2) and 114 +/- 51.0 (66-290), respectively. One hundred subjects, 50 in the low and 50 in the high activity group, were genotyped for CYP3A4*1B, *2, *4, *5, *6 and *10. Only 2 heterozygotes with genotype CYP3A4*1/*1B were found in the high CYP3A activity group. CYP3A4*2, *4, *5, *6 and *10 were not found in the subjects studied. CONCLUSION: This is the first investigation establishing CYP3A phenotypes and demonstrating the absence of common CYP3A4 genotypes in North Indians.
OBJECTIVES: To phenotype 200 healthy North Indians for cytochrome P450 3A (CYP3A) activity by measuring urinary ratio of 6beta-OH-cortisol/cortisol (6beta-OH-CS/CS) and to genotype the subjects demonstrating low and high CYP3A activity for the presence of CYP3A4*1B, *2, *4, *5, *6 and *10 alleles. METHODS: Morning spot urine samples were collected from 200 healthy North Indians. CS and 6beta-OH-CS were extracted and quantified by HPLC. Genotyping was performed by polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP). RESULTS: Urinary 6beta-OH-CS/CS ratio demonstrated a mean of 52.0 +/- 46 (1.1-290). North Indians demonstrated unimodal distribution with respect to urinary 6beta-OH-CS/CS ratio. On the basis of phenotypes, the subjects were divided into three groups demonstrating low (n = 50), intermediate (n = 100) and high (n = 50) CYP3A activity. These groups demonstrated 6beta-OH-CS/CS ratio of 13.4 +/- 5.2 (1.1-21.0), 40 +/- 11.9 (21.2-63.2) and 114 +/- 51.0 (66-290), respectively. One hundred subjects, 50 in the low and 50 in the high activity group, were genotyped for CYP3A4*1B, *2, *4, *5, *6 and *10. Only 2 heterozygotes with genotype CYP3A4*1/*1B were found in the high CYP3A activity group. CYP3A4*2, *4, *5, *6 and *10 were not found in the subjects studied. CONCLUSION: This is the first investigation establishing CYP3A phenotypes and demonstrating the absence of common CYP3A4 genotypes in North Indians.
Authors: B D Haehner; J C Gorski; M Vandenbranden; S A Wrighton; S K Janardan; P B Watkins; S D Hall Journal: Mol Pharmacol Date: 1996-07 Impact factor: 4.436
Authors: C Ged; J M Rouillon; L Pichard; J Combalbert; N Bressot; P Bories; H Michel; P Beaune; P Maurel Journal: Br J Clin Pharmacol Date: 1989-10 Impact factor: 4.335
Authors: J Christopher Gorski; Suda Vannaprasaht; Mitchell A Hamman; Walter T Ambrosius; Melissa A Bruce; Barbara Haehner-Daniels; Stephen D Hall Journal: Clin Pharmacol Ther Date: 2003-09 Impact factor: 6.875
Authors: Anna Westlind-Johnsson; Sarah Malmebo; Anna Johansson; Charlotta Otter; Tommy B Andersson; Inger Johansson; Robert J Edwards; Alan R Boobis; Magnus Ingelman-Sundberg Journal: Drug Metab Dispos Date: 2003-06 Impact factor: 3.922